$30 Million Cash Infusion for San Diego Firm, On Top of $20 Million from California Stem Cell Agency
A recent recipient of nearly $20 million from the California stem cell agency is on a financial roll this week as it pursues its efforts to translate what it says are "best-in-class gene therapy technologies into lifesaving cell therapies."
The firm is Poseida Therapeutics, Inc., of San Diego. Last October, it was awarded $19.8 million by the California …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.